GRAND RAPIDS - As local medical device companies look for new growth opportunities, they may do well to consider serving the burgeoning market in the Middle East, specifically Dubai. That?s the word from Don Beery, director of the two-dozen-member West Michigan Medical Device Consortium, who attended Arab Health 2013 in Dubai in late January. Beery
ALLEGAN - Perrigo Company announced that it has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately $283 million in cash. Founded in 1967, Rosemont is a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations. Rosemont's current portfolio
GRAND RAPIDS ? Carol Van Andel, wife of Van Andel Institute Chairman David Van Andel, has been named to the Davenport University board of trustees. She serves as Executive Director of the David and Carol Van Andel Foundation and has provided leadership and support to dozens of regional and national organizations focused on education, the
LANSING - Michigan's University Research Corridor generated $15.5 billion in economic impact statewide, exceeded $2 billion in annual research expenditures and awarded more than 31,600 degrees in one year, placing it at or near the top of seven university innovation clusters in the U.S., according to a new Economic Impact Report released Wednesday. The URC
ST. LOUIS - Wells Fargo Foundation announced recently an $8,000 grant awarded to Van Andel Institute to help fund the research of rare disorders being conducted at VAI in cooperation with clinical providers of Spectrum Health. The objective of this research effort is to identify causal mutations for rare diseases. Individuals afflicted by rare disease
LANSING - Food and animal safety products developer Neogen Corp. announced Thursday that it has acquired the assets of Scidera Genomics, LLC, an animal genomics business based in Davis, California. The company, formerly operated as MetaMorphix, Inc., or MMI Genomics, was a pioneer in the development of cattle, poultry, swine, and canine genetic testing. Scidera?s
PLYMOUTH - Tim Mayleben, the CFO of the original drug developer Esperion, has rejoined Esperion Therapeutics as president and CEO. Mayleben was a partner in Esperion when it was purchased in February 2004 by Pfizer for $1.3 billion. Roger Newton, who is the founder of Esperion, bought the company back from Pfizer several years ago.
ALLEGAN - Perrigo Company has completed the acquisition of Cobrek Pharmaceuticals, a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis. In May 2008, Perrigo acquired an 18.5 percent minority stake in Cobrek in conjunction with entering into a product development collaborative partnership agreement with the
KALAMAZOO - Michigan will get about $1.3 million from Pfizer in a deceptive marketing practice settlement with 33 states, a spokeswoman for Attorney General Bill Schuette said. The settlement resolves allegations that the New York-based drugmaker engaged in deceptive marketing practices in relation to two of its drugs, Zyvox and Lyrica. The judgment awarding Michigan's
LIVONIA - Harvard Drug Group landed a one-year contract modification worth up to $53.5 million from the U.S. Defense Logistics Agency, just days after closing on a $117 million product line acquisition. Harvard makes generics and over-the-counter drugs. The company has been a government contractor for more than 20 years and a supplier to the